Facebook
Twitter
Telegram
Report an ErrorKeros Therapeutics Cash Flow 2011-2024 | KROS
Annual Cash Flow Keros Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-125 M | -70.1 M | -62.1 M | -36.9 M | -16 M | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
815 K | 674 K | 378 K | 278 K | 208 K | - | - | - | - | - | - | - | - |
Accounts Payables |
5.45 M | 3.34 M | 3.64 M | 2.15 M | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
143 K | - | 18 M | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Keros Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-44.6 M | - | - | - | -34.2 M | - | -48.6 M | - | -1.43 M | - | -42.6 M | - | -10.5 M | - | -28.9 M | -18 M | -8.12 M | - | -10.5 M | -7.54 M | -2.51 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
277 K | - | - | - | 167 K | - | 547 K | - | 113 K | - | 274 K | - | 80 K | - | 203 K | 131 K | 63 K | - | 149 K | 94 K | 45 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
4.99 M | 5.45 M | 3.87 M | 4.15 M | 4.68 M | 3.34 M | 2.66 M | - | 3.06 M | 3.64 M | 2.81 M | 1.37 M | 3.01 M | 2.15 M | 2.15 M | 2.15 M | 2.15 M | 2.09 M | 2.09 M | 2.09 M | 2.09 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
226 K | 143 K | - | - | - | - | - | - | - | 18 M | - | 100 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency